Cancer Vaccines

Scientists See Hope for Cervical Cancer Vaccine

Published in Cancer Weekly, June 29th, 1998

Scientists who hope one day to immunize girls against cervical cancer have begun the first human testing of a possible vaccine.

It's far too soon to know if Merck & Co.'s experimental vaccine, described at a biotechnology meeting, will work. The company is in the first stage of testing, to make sure the vaccine is safe enough to study in large numbers of women. But it's a long-awaited step.

"We have an exciting opportunity," said Dr. Katherin Jansen, Merck, as she reported that the vaccine seemed highly effective in animals.

At issue is human papilloma virus (HPV), the nation's most common sexually transmitted disease.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-06-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry